Stocks Hitting 52-Week Highs

shares gained 0.80% to reach a new 52-week high of $74.80.

entered into 3 agreements with Quest Diagnostics.

shares rose 1.82% to touch a new 52-week high of $72.16. ResMed shares have jumped 59.12% over the past 52 weeks, while the S&P 500 index has gained 11.47% in the same period.

shares jumped 36.60% to reach a new 52-week high of $5.31 after

announced its plans to acquire Vitesse Semiconductor for $5.28 per share.

shares rose 6.55% to touch a new 52-week high of $7.65. Trovagene named Matthew Posard as Chief Commercial Officer.